Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction o

Author:  ["Emily Pisha","Heebyung Chai","Ik-Soo Lee","Tangai E. Chagwedera","Norman R. Farnsworth","Geoffrey A. Cordell","Christopher W.W. Beecher","Harry H.S. Fong","A. Douglas Kinghorn","Daniel M. Brown","Mansukh C. Wani","Monroe E. Wall","Tina J. Hieken","Tapas K. Das Gupta","John M. Pezzuto"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

As a result of bioassay–guided fractionation, betulinic acid, a pentacyclic triterpene, was identified as a melanoma–specific cytotoxic agent. In follow–up studies conducted with athymic mice carrying human melanomas, tumour growth was completely inhibited without toxicity. As judged by a variety of cellular responses, antitumour activity was mediated by the induction of apoptosis. Betulinic acid is inexpensive and available in abundant supply from common natural sources, notably the bark of white birch trees. The compound is currently undergoing preciinicai development for the treatment or prevention of malignant melanoma.

Cite this article

Pisha, E., Chai, H., Lee, IS. et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med 1, 1046–1051 (1995). https://doi.org/10.1038/nm1095-1046

View full text

>> Full Text:   Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction o

Identification of an endogenous inhibitor of prostatic carcinoma cell growth

Magnetic resonance mapping demonstrates benefits of VEGF–induced myocardial angiogenesis